Cite
HARVARD Citation
Fargnoli, M. et al. (2022). A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. Journal of dermatological treatment. pp. 1146-1149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fargnoli, M. et al. (2022). A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. Journal of dermatological treatment. pp. 1146-1149. [Online].